Skip to main content
Homepage
PARTIAL Analysis Report
Sep 3, 2026
59 days ago · 2% complete
Partial analysis — no complete end-to-end run on record.
No report run on this ticker yet Only preliminary foundational data below
NOT YET RESEARCHED No report has been run on BCPC yet. What you are seeing is foundational data only — price, profile and filings — not the full analysis (lenses, memo, scores and the AI panel arrive with the first report).
For AI assistants & researchers — machine-readable summary of this page

What this page is: Delvantic's full research page for Balchem Corporation (BCPC) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.

Page map (sections in order; each card carries a stable reference-name attribute you can cite):

  • profile-header / price-overview — company profile, live quote, market cap
  • extended-analysis — the core: three AI lens reads with findings, scores, and the analyst memo
  • future-predictions — our forward price-band predictions
  • market-narrative / ai-findings / gpt-critique — narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)
  • Members-only sections (render as login gates for anonymous readers): price-history, income-trend, key-metrics, financials (statement tables), insider-trading. The analysis above is public; the raw data tables require a free account.

More for machine readers: site briefing at /llms.txt · any ticker resolves at voiceoftrades.com/stock/TICKER · raw inputs are public-company filings and market data (via licensed data feeds); every model, score, lens read, and prediction on this page is Delvantic's own analysis.

Balchem Corporation

BCPC NASDAQ
Basic Materials · Specialty Chemicals
Montvale, NJ 07645, United States balchem.com Updated Nov 1, 8:14pm
Price
$171.75
Market Cap
$5.5B
Employees
1,368
Beta
0.81
Avg Volume
179,482
Last Dividend
$0.96
CEO
Mr. Theodore Lee Harris

Balchem Corporation is a specialty ingredients and solutions company that develops, manufactures, and distributes performance products for nutrition, food, pharmaceuticals, animal health, medical device sterilization, plant nutrition, and industrial applications. The company operates through three main segments: Human Nutrition and Health, which supplies ingredients and delivery systems used in food, beverage, and supplement formulations; Animal Nutrition and Health, which provides nutritional ingredients and technologies for livestock and companion animal markets; and Specialty Products, which includes packaged performance gases and chemical products used in healthcare and other industrial settings. Balchem Corporation serves customers worldwide by combining formulation expertise, ingredient functionality, and application-specific technologies. Founded in 1967 and headquartered in Montvale, New Jersey, Balchem Corporation plays a broad role in specialty ingredient supply chains across health, nutrition, and industrial markets.

Runs with full report
Price Overview
Current data · timestamped when a report runs
$165.23
Change
-1.60 (-0.96%)
Day Range
$163.93 – $167.27
52-Week Range
$139.17 – $183.90
50-Day MA
$170.94
200-Day MA
$167.15
Volume
5,804.00
0Company Classification 1Industry Landscape 2Company Momentum 3Forward Projection 4aDCF Valuation 4bEarnings Power Value 4cAnchored PE 4dReverse DCF 4eRevenue-Based DCF 4fAnchored P/S 4gScenario Analysis 4hDividend Discount Model 4iBook Value Analysis 4jInsider Activity 4fCash Flow Quality 4gDebt Maturity Risk 4hMacro Environment 4iSector Intelligence 4jRevenue Confidence 4kSensitivity Analysis 4lSector Demand Cycle 5AI Investigation 5bThesis Evaluation 6Valuation Synthesis
computed not applicable not yet run 1 computed · 6 not applicable · 17 not yet run
Narrative Economics
The story the market is telling about this stock — the intangible X-factor (founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for BCPC — it's generated by the pipeline (market-narrative step).
Claude Reading
Claude Opus reviews the pipeline's raw data + every prior verdict, then writes an independent take.
No AI findings yet for BCPC — they're generated by the pipeline (ai-findings step) when a report is run on this ticker.
GPT Reading
GPT reads the identical raw briefing blind — one of the Big-3 independent readings — and commits to its own verdict.
No GPT reading yet for BCPC — it's generated by the pipeline (gpt-critique step) after the other Big-3 seats, when a report is run on this ticker.
Grok Reading
Grok (xAI) reads the identical raw briefing blind — one of the Big-3 independent readings — and commits to its own verdict.
No Grok reading yet for BCPC — it's generated by the pipeline (grok-critique step) alongside the other Big-3 seats, when a report is run on this ticker.
Advanced Analysis Forensic deep-dive · separate lenses
A separate, manually-run forensic pipeline (dilution, earnings quality, liquidity → two scored lenses → the play). Hasn't been run for this ticker yet.
Community AI Feedback
No community reviews yet for BCPC. Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes personal — only you see this